Christopher Haqq
Directeur Technique/Scientifique/R&D chez ELICIO THERAPEUTICS, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Christopher Haqq
Sociétés | Poste | Début | Fin |
---|---|---|---|
ELICIO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2019 | - |
Historique de carrière de Christopher Haqq
Anciens postes connus de Christopher Haqq
Sociétés | Poste | Début | Fin |
---|---|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/10/2019 | 01/06/2023 |
SURROZEN, INC. | Directeur/Membre du Conseil | 01/11/2020 | 01/04/2021 |
Independent Dir/Board Member | 01/11/2020 | 01/04/2021 | |
ATARA BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2012 | 25/10/2019 |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Directeur Technique/Scientifique/R&D | 29/07/2009 | 01/09/2011 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Directeur Technique/Scientifique/R&D | 01/03/2007 | 13/07/2009 |
The University of California, San Francisco | Corporate Officer/Principal | - | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
Formation de Christopher Haqq
Harvard Medical School | Doctorate Degree |
Stanford University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 7 |
Consumer Services | 4 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
AMGEN INC. | Health Technology |
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
ELICIO THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
Consonance-HFW Acquisition Corp.
Consonance-HFW Acquisition Corp. Financial ConglomeratesFinance Consonance-HFW Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisitions, share purchase, reorganization, or similar business combination. The company was founded by Gad Soffer and Kevin Harold Livingston on August 21, 2020 and is headquartered in Princeton, NJ. | Finance |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Christopher Haqq
- Expérience